$RKLB
Rocket Lab USA, Inc. Stock $rklb

$rklb Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-K Financial Statement

#000095017022004458 Filed on March 24, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021
Revenue	$40.70M	$27.48M	$62.24M
YoY Change	123.74%	74.61%	77.01%
Cost Of Revenue	$36.97M	$20.79M	$64.13M
YoY Change	120.3%	5.06%	36.51%
Gross Profit	$3.735M	$6.685M	-$1.893M
YoY Change	164.71%	-264.9%	-83.98%
Gross Profit Margin	9.18%	24.33%	-3.04%
Selling, General & Admin	$23.08M	$18.74M	$58.40M
YoY Change	248.4%	187.57%	143.38%
% of Gross Profit	617.88%	280.3%
Research & Development	$13.48M	$10.58M	$41.77M
YoY Change	90.41%	33.64%	118.19%
% of Gross Profit	360.83%	158.32%
Depreciation & Amortization	$3.093M	$3.441M	$7.530M
YoY Change	76.04%	17.08%	15.24%
% of Gross Profit	82.81%	51.47%
Operating Expenses	$36.56M	$31.02M	$100.2M
YoY Change	166.79%	110.31%	132.2%
Operating Profit	-$32.82M	-$24.33M	-$102.1M
YoY Change	167.02%	29.41%	85.71%
Interest Expense	-$2.989M	-$2.929M	-$6.128M
YoY Change	2253.54%	-197.8%	-2835.71%
% of Operating Profit
Other Income/Expense, Net	$10.50M	$23.92M	-$22.79M
YoY Change	-415.57%	-1087.41%	-5604.11%
Pretax Income	-$22.32M	-$3.345M	-$124.8M
YoY Change	42.92%	-81.65%	128.9%
Income Tax	$4.388M	-$6.541M	-$7.520M
% Of Pretax Income
Net Earnings	-$26.71M	$3.196M	-$117.3M
YoY Change	68.17%	-116.87%	113.29%
Net Earnings / Revenue	-65.62%	11.63%	-188.51%
Basic Earnings Per Share	-$0.06		-$0.56
Diluted Earnings Per Share	-$58.51K	$7.073K	-$558.9K
COMMON SHARES
Basic Shares Outstanding	464.8M		209.9M
Diluted Shares Outstanding	456.5M		209.9M

Balance Sheet

Concept	2022 Q1	2021 Q4	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$603.1M	$691.0M	$691.0M
YoY Change	1662.14%	79696.63%	1208.83%
Cash & Equivalents	$603.1M	$691.0M	$691.0M
Short-Term Investments
Other Short-Term Assets	$4.766M	$2.104M	$16.89M
YoY Change	-41.33%	130.2%	376.88%
Inventory	$77.89M	$47.90M	$47.90M
Prepaid Expenses	$17.91M	$14.79M
Receivables	$32.99M	$13.96M	$16.45M
Other Receivables	$3.635M	$0.00	$2.563M
Total Short-Term Assets	$746.2M	$774.8M	$774.8M
YoY Change	924.6%	732.06%	732.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$99.55M	$65.34M	$93.76M
YoY Change	30.57%	31.12%	22.19%
Goodwill	$58.77M	$43.31M
YoY Change		1282.32%
Intangibles	$87.62M	$57.49M
YoY Change		406.54%
Long-Term Investments
YoY Change
Other Assets	$3.990M	$4.550M	$11.53M
YoY Change	-21.19%		225.66%
Total Long-Term Assets	$311.3M	$206.1M	$206.1M
YoY Change	225.49%	117.49%	117.49%
TOTAL ASSETS
Total Short-Term Assets	$746.2M	$774.8M	$774.8M
Total Long-Term Assets	$311.3M	$206.1M	$206.1M
Total Assets	$1.057B	$980.8M	$980.8M
YoY Change	527.71%	422.09%	422.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.11M	$3.489M	$3.489M
YoY Change	271.25%	3.59%	3.59%
Accrued Expenses	$17.05M	$10.98M	$13.36M
YoY Change	155.1%	67.05%	103.32%
Deferred Revenue	$97.12M	$59.75M
YoY Change		128.64%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.846M	$2.827M	$2.827M
YoY Change
Total Short-Term Liabilities	$173.4M	$96.31M	$96.31M
YoY Change	338.97%	98.9%	98.9%
LONG-TERM LIABILITIES
Long-Term Debt	$97.97M	$97.30M	$97.30M
YoY Change
Other Long-Term Liabilities	$4.901M	$1.800M	$88.33M
YoY Change	-85.68%	-53.83%	183.12%
Total Long-Term Liabilities	$102.9M	$99.10M	$185.6M
YoY Change	200.66%	2441.6%	494.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$173.4M	$96.31M	$96.31M
Total Long-Term Liabilities	$102.9M	$99.10M	$185.6M
Total Liabilities	$324.9M	$282.4M	$282.4M
YoY Change	340.75%	254.7%	254.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$331.7M	-$305.0M
YoY Change		62.51%
Common Stock	$46.00K	$45.00K
YoY Change		462.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$732.6M	$698.4M	$698.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.057B	$980.8M	$980.8M
YoY Change	527.71%	422.09%	422.09%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021
OPERATING ACTIVITIES
Net Income	-$26.71M	$3.196M	-$117.3M
YoY Change	68.17%	-116.87%	113.29%
Depreciation, Depletion And Amortization	$3.093M	$3.441M	$7.530M
YoY Change	76.04%	17.08%	15.24%
Cash From Operating Activities	-$26.34M	-$21.91M	-$71.79M
YoY Change	70.16%	245.54%	158.64%
INVESTING ACTIVITIES
Capital Expenditures	$6.242M	-$14.25M	$25.70M
YoY Change	54.28%	93.35%	2.3%
Acquisitions	$65.59M		$66.44M
YoY Change			444.19%
Other Investing Activities	-$65.59M	-$66.44M	-$66.44M
YoY Change		-246155.56%	445.4%
Cash From Investing Activities	-$71.83M	-$80.69M	-$92.13M
YoY Change	1675.33%	998.68%	146.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	14.44M	-1.840M	799.9M
YoY Change	3388.89%	-402.13%	3624.46%
NET CHANGE
Cash From Operating Activities	-26.34M	-21.91M	-71.79M
Cash From Investing Activities	-71.83M	-80.69M	-92.13M
Cash From Financing Activities	14.44M	-1.840M	799.9M
Net Change In Cash	-84.30M	-104.4M	638.1M
YoY Change	353.37%	698.66%	-1558.24%
FREE CASH FLOW
Cash From Operating Activities	-$26.34M	-$21.91M	-$71.79M
Capital Expenditures	$6.242M	-$14.25M	$25.70M
Free Cash Flow	-$32.58M	-$7.662M	-$97.49M
YoY Change	66.87%	-844.61%	84.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
CY2020	rklb	Proceeds From Business Combination And Pipe Investment Net Of Transaction Costs ProceedsFromBusinessCombinationAndPipeInvestmentNetOfTransactionCosts
CY2020	rklb	Unpaid Transaction Costs UnpaidTransactionCosts
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
CY2020	rklb	Warrants And Right Outstanding WarrantsAndRightOutstanding
CY2020	us-gaap	Interest Paid Net InterestPaidNet
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
CY2020	rklb	Amortization Of Inventory Step Up AmortizationOfInventoryStepUp
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm2
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021	rklb	Issuance Of Common Stock Warrants And Accrued Issuance Costs Connection With Loan And Security Agreement IssuanceOfCommonStockWarrantsAndAccruedIssuanceCostsConnectionWithLoanAndSecurityAgreement
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageRemainingContractualTerm2
CY2020	rklb	Repurchase Of Shares And Options From Management RepurchaseOfSharesAndOptionsFromManagement
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit
CY2020	rklb	Contingent Consideration Assumed At Acquisitions ContingentConsiderationAssumedAtAcquisitions
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001819994
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39560
CY2021	dei	Entity Registrant Name EntityRegistrantName	ROCKET LAB USA, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1550340
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	3881 McGowen Street
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Long Beach
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90808
CY2021	dei	City Area Code CityAreaCode	714
CY2021	dei	Local Phone Number LocalPhoneNumber	465-5737
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	348500000
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	464776507
CY2021	dei	Auditor Firm AuditorFirmId	34
CY2021	dei	Auditor Name AuditorName	Deloitte & Touche, LLP
CY2021	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	690959000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52792000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13957000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2730000
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2490000
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2045000
CY2021Q4	us-gaap	Inventory Net InventoryNet	47904000
CY2020Q4	us-gaap	Inventory Net InventoryNet	26135000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19454000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9412000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	774764000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	93114000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	65339000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49832000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	57487000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11349000
CY2021Q4	us-gaap	Goodwill Goodwill	43308000
CY2020Q4	us-gaap	Goodwill Goodwill	3133000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	28424000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26902000
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1116000
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1141000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5859000
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2398000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4550000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0
CY2021Q4	us-gaap	Assets Assets	980847000
CY2020Q4	us-gaap	Assets Assets	187869000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3489000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3368000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10977000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6571000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8266000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4582000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	59749000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	26132000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2827000
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10999000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7766000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	96307000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	48419000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	97297000
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28302000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27299000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	466000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	58227000
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1800000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3899000
CY2021Q4	us-gaap	Liabilities Liabilities	282399000
CY2020Q4	us-gaap	Liabilities Liabilities	79617000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	416744314
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	450180479
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	450180479
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78410162
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78410162
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	45000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	8000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1002106000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19920000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-305011000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-187691000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1308000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1055000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	698448000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-166708000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	980847000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	187869000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	62237000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35160000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	64130000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	46977000
CY2021	us-gaap	Gross Profit GrossProfit	-1893000
CY2020	us-gaap	Gross Profit GrossProfit	-11817000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41765000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19142000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	58395000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23993000
CY2021	us-gaap	Operating Expenses OperatingExpenses	100160000
CY2020	us-gaap	Operating Expenses OperatingExpenses	43135000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-102053000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-54952000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-6128000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	224000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-567000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2420000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	15294000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2417000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-798000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	187000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-22787000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	414000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-124840000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54538000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7520000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	467000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-117320000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-55005000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	253000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1134000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-117067000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53871000
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.56
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.73
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	209895135
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	75414888
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-118529000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-55005000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	978000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4218000
CY2020	rklb	Stock Issued During Period Value Common Stock Warrant StockIssuedDuringPeriodValueCommonStockWarrant	496000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1134000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-166708000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-117320000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3122000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	33108000
CY2021	rklb	Stock Issued During Period Value Preferred Stock Warrants Exercised StockIssuedDuringPeriodValuePreferredStockWarrantsExercised	6514000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2975000
CY2021	rklb	Conversion Of Public Warrants For Common Stock ConversionOfPublicWarrantsForCommonStock	35000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	274961000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	11568000
CY2021	rklb	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	649940000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	253000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	698448000
CY2021	us-gaap	Profit Loss ProfitLoss	-117320000
CY2020	us-gaap	Profit Loss ProfitLoss	-55005000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10851000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9339000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	32557000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	4218000
CY2021	rklb	Amortization Of Inventory Step Up AmortizationOfInventoryStepUp	616000
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-156000
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1473000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-496000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1546000
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	2010000
CY2020	us-gaap	Other Noncash Expense OtherNoncashExpense	1533000
CY2021	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	15294000
CY2020	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	2615000
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-9979000
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-713000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7789000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	522000
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-1816000
CY2020	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-5019000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12688000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11260000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10504000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2375000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	4548000
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-4517000
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1603000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3074000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4104000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-326000
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1538000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	28057000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	15921000
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	838000
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-832000
CY2021	rklb	Increase Decrease In Non Current Lease Liabilities IncreaseDecreaseInNonCurrentLeaseLiabilities	-1801000
CY2020	rklb	Increase Decrease In Non Current Lease Liabilities IncreaseDecreaseInNonCurrentLeaseLiabilities	-965000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	370000
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-242000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-71791000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-27757000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25699000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25121000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	66435000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	12208000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-92134000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37329000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3147000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	978000
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	15000000
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	98895000
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	15000000
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	20500000
CY2021	rklb	Proceeds From Business Combination And Pipe Investment Net Of Transaction Costs ProceedsFromBusinessCombinationAndPipeInvestmentNetOfTransactionCosts	728255000
CY2021	rklb	Repurchase Of Shares And Options From Management RepurchaseOfSharesAndOptionsFromManagement	30358000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	799939000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21478000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2128000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-153000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	638142000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-43761000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53933000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97694000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	692075000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53933000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	3991000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1842000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-300000
CY2021	rklb	Unpaid Purchases Of Property Equipment And Software UnpaidPurchasesOfPropertyEquipmentAndSoftware	938000
CY2020	rklb	Unpaid Purchases Of Property Equipment And Software UnpaidPurchasesOfPropertyEquipmentAndSoftware	2090000
CY2020	rklb	Issuance Of Common Stock Warrants And Accrued Issuance Costs Connection With Loan And Security Agreement IssuanceOfCommonStockWarrantsAndAccruedIssuanceCostsConnectionWithLoanAndSecurityAgreement	677000
CY2021	rklb	Unpaid Transaction Costs UnpaidTransactionCosts	27000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3916000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2410000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	11568000
CY2021	rklb	Contingent Consideration Assumed At Acquisitions ContingentConsiderationAssumedAtAcquisitions	-7300000
CY2021	rklb	Warrants And Right Outstanding WarrantsAndRightOutstanding	48149000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	219000
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	447919591
CY2021Q4	us-gaap	Cash Cash	310330000
CY2021Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	49075000
CY2021	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	728255000
CY2021Q4	rklb	Accrued Transaction Costs AccruedTransactionCosts	27000
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	219000
CY2021	rklb	Warrants And Right Outstanding WarrantsAndRightOutstanding	48149000
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	30358000
CY2021	rklb	Reverse Recapitalization Net Of Transaction Costs ReverseRecapitalizationNetOfTransactionCosts	649940000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021	rklb	Stockholders Equity Note Stock Splitexchange Ratio StockholdersEquityNoteStockSplitexchangeRatio	9.059659
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On an ongoing basis, our management evaluates estimates and assumptions including those related to revenue recognition, contract costs, loss reserves, valuation of warrants and stock-based compensation and deferred tax valuation allowances. We based our estimates on historical data and experience, as well as various other factors that our management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. Actual results could differ from these estimates and assumptions.</span></p>
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	59749000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	26132000
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	914000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19454000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9412000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	87530000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	65680000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22191000
CY2019Q4	us-gaap	Goodwill Goodwill	0
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1116000
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1141000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15848000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	65339000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49832000
CY2021	us-gaap	Depreciation Depreciation	7530000
CY2020	us-gaap	Depreciation Depreciation	6534000
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	5238000
CY2021	rklb	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Warrants To Purchase FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfWarrantsToPurchase	-6514000
CY2021	rklb	Fairvalue Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exchange Of Warrants To Purchase FairvalueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExchangeOfWarrantsToPurchase	-2975000
CY2020Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	5870000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2104000
CY2021Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	13957000
CY2020	rklb	Grant Proceeds GrantProceeds	3695000
CY2021	rklb	Percentage Of Tax Incentive Reimburse PercentageOfTaxIncentiveReimburse	0.15
CY2021	rklb	Proceeds From Research And Development ProceedsFromResearchAndDevelopment	393000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	Forfeitures are recognized as incurred for as they occur. Unless otherwise approved, options must be exercised while the individual is an employee or within 90-days of termination when applicable. The expiration date of newly issued options is ten years after grant date unless earlier terminated as provided for in the Plan.
CY2020Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	2730000
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2490000
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2045000
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	62237000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35160000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	26132000
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10211000
CY2021	rklb	Contract Liabilities Assumed At Acquisition ContractLiabilitiesAssumedAtAcquisition	5560000
CY2020	rklb	Contract Liabilities Assumed At Acquisition ContractLiabilitiesAssumedAtAcquisition	0
CY2021	rklb	Contract With Customer Liability Current Additions1 ContractWithCustomerLiabilityCurrentAdditions1	41614000
CY2020	rklb	Contract With Customer Liability Current Additions1 ContractWithCustomerLiabilityCurrentAdditions1	24694000
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	13557000
CY2020	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	8773000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	59749000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	26132000
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	241463000
CY2021	us-gaap	Revenue Performance Obligation Description Of Timing RevenuePerformanceObligationDescriptionOfTiming	approximately 60% is expected to be recognized within 12 months, with the remaining 40% to be recognized beyond 12 months
CY2019Q4	us-gaap	Goodwill Goodwill	0
CY2021	rklb	Recognized Performance Reserve Payments RecognizedPerformanceReservePayments	1895000
CY2021Q4	rklb	Number Of Missions Launched NumberOfMissionsLaunched	100
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1284000
CY2020	rklb	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cost Of Warrants Vesting FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCostOfWarrantsVesting	198000
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2417000
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3899000
CY2021	rklb	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cost Of Warrants Vesting FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCostOfWarrantsVesting	352000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	21517000
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	14023000
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	24166000
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	12112000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2221000
CY2021Q4	us-gaap	Inventory Net InventoryNet	47904000
CY2020Q4	us-gaap	Inventory Net InventoryNet	26135000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	14787000
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2628000
CY2021Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	2563000
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2895000
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	238000
CY2020Q4	us-gaap	Goodwill Goodwill	3133000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	40110000
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	65000
CY2021Q4	us-gaap	Goodwill Goodwill	43308000
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	64259000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6772000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	57487000
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	15021000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3672000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11349000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3321000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2222000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4218000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27263775
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.97
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8118000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7371000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7161000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7066000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7037000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	18934000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	55687000
CY2021Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	100000000
CY2021	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	1000000
CY2021	rklb	Line Of Credit Facility Front End Fee Amount LineOfCreditFacilityFrontEndFeeAmount	3250000
CY2021Q4	rklb	Current Insallments Of Long Term Borrowings CurrentInsallmentsOfLongTermBorrowings	2827000
CY2020Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	35000000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	496000
CY2020Q4	rklb	Class Of Warrant Or Right Fair Value ClassOfWarrantOrRightFairValue	2433000
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6514000
CY2021	us-gaap	Preferred Stock Convertible Conversion Price Decrease PreferredStockConvertibleConversionPriceDecrease	9.059659
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32557000
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.50
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y11M12D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11941000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	90597
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.41
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.78
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2771051
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.36
CY2020	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriodWeightedAverageRemainingContractualTerm2	P3Y2M15D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2565000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1508243
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.26
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	986352
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.05
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22088726
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.03
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.53
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M13D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	85853000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3708786
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.00
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Exercised Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageExercisedDateFairValue	0.51
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriodWeightedAverageRemainingContractualTerm2	P4Y3M25D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	41822000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	857579
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.21
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Forfeited Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageForfeitedDateFairValue	0.60
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageRemainingContractualTerm2	P0Y3D
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue	9131000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	177033
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.16
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Weighted Average Expired Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageExpiredDateFairValue	0.31
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue	1969000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17345328
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.03
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.54
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	195111000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	15112440
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.01
CY2021Q4	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue	0.52
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y10M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	170320000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	14739214
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.97
CY2020Q4	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue	0.49
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y9M29D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	57660000
CY2021Q4	us-gaap	Share Price SharePrice	0
CY2020Q4	us-gaap	Share Price SharePrice	1.41
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.600
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.006
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9642000
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	359000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	441000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	277000
CY2021Q4	rklb	Lease Liability LeaseLiability	30685000
CY2020Q4	rklb	Lease Liability LeaseLiability	28969000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	3356000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	2552000
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	583000
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	95000
CY2020	rklb	Finance Lease Cost FinanceLeaseCost	678000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1534
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	3051000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	2080000
CY2021	rklb	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	0
CY2020	rklb	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	95000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3916000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2410000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y7M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y1M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3799000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4076000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3984000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3728000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3790000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	21636000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	41013000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10328000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	30685000
CY2021Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	4803000
CY2020	rklb	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	-0.0037
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2399000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0192
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-203000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0037
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	19151000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-132585000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-56439000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	7745000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1901000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-124840000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54538000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2377000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1410000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2379000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1410000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5957000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-339000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3603000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	943000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9899000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	943000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7520000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	467000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	26216000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	11453000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-477000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.0038
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	634000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.0116
CY2021	rklb	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsAmount	2421000
CY2021	rklb	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	-0.0194
CY2020	rklb	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsAmount	200000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11289000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2070
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7520000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0602
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	467000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0086
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	2105000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	1969000
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	409000
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	353000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	14160000
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	5503000
CY2021Q4	rklb	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	7244000
CY2020Q4	rklb	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	7426000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	7950000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	2082000
CY2021Q4	rklb	Deferred Tax Assets Warrants DeferredTaxAssetsWarrants	0
CY2020Q4	rklb	Deferred Tax Assets Warrants DeferredTaxAssetsWarrants	519000
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	1075000
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	0
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	41688000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30264000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	898000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	923000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	75529000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	49043000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	58235000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39084000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17294000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9959000
CY2021Q4	rklb	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	-6723000
CY2020Q4	rklb	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	-6954000
CY2021Q4	rklb	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	-5160000
CY2020Q4	rklb	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	0
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	18000
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0
CY2021Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	0
CY2020Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	757000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	11901000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7711000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	5393000
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2248000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	58235000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39084000
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	6762000
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6296000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	835000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	800000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	667000
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	632000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	800000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	800000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	35000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	835000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	800000
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	195305000
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	143712000
CY2021	us-gaap	Capitalized Contract Cost Amortization Method CapitalizedContractCostAmortizationMethod	Capitalized costs are required to be amortized over five years (15 years for expenditures attributable to foreign research).
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	0
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-117320000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-55005000
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	209895135
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	75414888
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.56
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.73
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	62237000
CY2021	rklb	Percentage Of Total Revenue PercentageOfTotalRevenue	1
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	35160000
CY2020	rklb	Percentage Of Total Revenue PercentageOfTotalRevenue	1
CY2021Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.05
CY2020Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	0

Files In Submission

Name	View Source	Status
0000950170-22-004458-index-headers.html	Edgar Link	pending
0000950170-22-004458-index.html	Edgar Link	pending
0000950170-22-004458.txt	Edgar Link	pending
0000950170-22-004458-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
rklb-20211231.htm	Edgar Link	pending
rklb-20211231.xsd	Edgar Link	pending
rklb-20211231_cal.xml	Edgar Link	unprocessable
rklb-20211231_def.xml	Edgar Link	unprocessable
rklb-20211231_htm.xml	Edgar Link	completed
rklb-20211231_lab.xml	Edgar Link	unprocessable
rklb-20211231_pre.xml	Edgar Link	unprocessable
rklb-ex10_27.htm	Edgar Link	pending
rklb-ex21_1.htm	Edgar Link	pending
rklb-ex23_1.htm	Edgar Link	pending
rklb-ex31_1.htm	Edgar Link	pending
rklb-ex31_2.htm	Edgar Link	pending
rklb-ex32_1.htm	Edgar Link	pending
rklb-ex4_1.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RKLB
Rocket Lab USA, Inc. Stock $rklb

2022 Q1 Form 10-K Financial Statement

#000095017022004458 Filed on March 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RKLB Rocket Lab USA, Inc. Stock $rklb

2022 Q1 Form 10-K Financial Statement

#000095017022004458 Filed on March 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RKLB
Rocket Lab USA, Inc. Stock $rklb